Umbelliprenin

CAS No. 23838-17-7

Umbelliprenin( —— )

Catalog No. M24098 CAS No. 23838-17-7

Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 123 In Stock
5MG 117 In Stock
10MG 170 In Stock
25MG 297 In Stock
50MG 434 In Stock
100MG 622 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Umbelliprenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.
  • Description
    Umbelliprenin alleviated neuropathic pain, and decreased serum IL-6 levels and oxidative stress.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL-6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23838-17-7
  • Formula Weight
    366.49
  • Molecular Formula
    C24H30O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 5 mg/ml (13.64 mM); DMF: 30 mg/ml (81.85 mM)
  • SMILES
    CC(C)=CCC/C(/C)=C/CC/C(/C)=C/COc(cc1)cc(O2)c1C=CC2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Shahraki J, et al. Umbelliprenin relieves paclitaxel-induced neuropathy. J Pharm Pharmacol. 2020 Dec;72(12):1822-1829.
molnova catalog
related products
  • 2-Benzothiazolamine

    2-Aminobenzothiazole is an organic compound.

  • Chrysosplenol D

    Chrysosplenol D, an efflux pump inhibitor that can potentiate the activity of commercially important antibiotics and antimalarials.

  • Canakinumab

    Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively.